| Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction MA Pfeffer, GA Lamas, DE Vaughan, AF Parisi, E Braunwald New England Journal of Medicine 319 (2), 80-86, 1988 | 1372 | 1988 |
| Angiotensin-converting enzyme inhibitors NJ Brown, DE Vaughan Circulation 97 (14), 1411-1420, 1998 | 1070 | 1998 |
| Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. DE Vaughan, SA Lazos, K Tong The Journal of clinical investigation 95 (3), 995-1001, 1995 | 761 | 1995 |
| Endogenous tissue-type plasminogen activator and risk of myocardial infarction PM Ridker, DE Vaughan, J Manson, CH Hennekens, M Stampfer The Lancet 341 (8854), 1165-1168, 1993 | 755 | 1993 |
| PAI‐1 in tissue fibrosis AK Ghosh, DE Vaughan Journal of cellular physiology 227 (2), 493-507, 2012 | 712 | 2012 |
| Established and emerging plasma biomarkers in the prediction of first atherothrombotic events PM Ridker, NJ Brown, DE Vaughan, DG Harrison, JL Mehta Circulation 109 (25_suppl_1), IV-6-IV-19, 2004 | 629 | 2004 |
| PAI‐1 and atherothrombosis DE Vaughan Journal of Thrombosis and Haemostasis 3 (8), 1879-1883, 2005 | 625 | 2005 |
| Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic … PM Ridker, CL Gaboury, PR Conlin, EW Seely, GH Williams, DE Vaughan Circulation 87 (6), 1969-1973, 1993 | 589 | 1993 |
| Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1 LJ Ma, SL Mao, KL Taylor, T Kanjanabuch, YF Guan, YH Zhang, ... Diabetes 53 (2), 336-346, 2004 | 529 | 2004 |
| Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism SZ Goldhaber, J Heit, G Sharma, JS Nagel, D Kim, JA Parker, D Drum, ... The Lancet 332 (8606), 293-298, 1988 | 520 | 1988 |
| The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data VJ Dzau, K Bernstein, D Celermajer, J Cohen, B Dahlöf, J Deanfield, ... The American journal of cardiology 88 (9), 1-20, 2001 | 519 | 2001 |
| Molecular and physiological manifestations and measurement of aging in humans SS Khan, BD Singer, DE Vaughan Aging cell 16 (4), 624-633, 2017 | 476 | 2017 |
| Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial JH Traverse, TD Henry, CJ Pepine, JT Willerson, DXM Zhao, SG Ellis, ... Jama 308 (22), 2380-2389, 2012 | 464 | 2012 |
| Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME … JH Traverse, TD Henry, SG Ellis, CJ Pepine, JT Willerson, DXM Zhao, ... Jama 306 (19), 2110-2119, 2011 | 464 | 2011 |
| Identification of authentic estrogen receptor in cultured endothelial cells: a potential mechanism for steroid hormone regulation of endothelial function CD Venkov, AB Rankin, DE Vaughan Circulation 94 (4), 727-733, 1996 | 458 | 1996 |
| Prospective study of endogenous tissue plasminogen activator and risk of stroke PM Ridker, CH Hennekens, JE Manson, DE Vaughan, MJ Stampfer The Lancet 343 (8903), 940-943, 1994 | 445 | 1994 |
| Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function Z Lin, A Kumar, S SenBanerjee, K Staniszewski, K Parmar, DE Vaughan, ... Circulation research 96 (5), e48-e57, 2005 | 442 | 2005 |
| Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape GF Mitchell, GA Lamas, DE Vaughan, MA Pfeffer Journal of the American College of Cardiology 19 (6), 1136-1144, 1992 | 425 | 1992 |
| Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator PM Ridker, DE Vaughan, MJ Stampfer, RJ Glynn, CH Hennekens Jama 272 (12), 929-933, 1994 | 423 | 1994 |
| Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. DM Kerins, Q Hao, DE Vaughan The Journal of clinical investigation 96 (5), 2515-2520, 1995 | 422 | 1995 |
